Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
Converging Roads Between HIV and Cancer Research

In 2017, a key focus in the field of HIV will be investigating new ways to tackle persistence via interactions and synergies with other fields such as cancer research and immune-based therapies. This will take centre stage when the scientific community convenes in July 2017 at the IAS HIV Cure & Cancer Forum and the 9th IAS Conference on HIV Science (IAS 2017).

Published
18 hours ago
From
International AIDS Society
Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research

Gilead Sciences, Inc. today announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects. These projects will be conducted by leading academic institutions, non-profit organizations and community groups from around the world, focusing on three key areas: translational research, efficacy studies in animal models and community perspectives of HIV cure.

Published
10 January 2017
From
Gilead press release
How close are we to a cure for HIV? A Q&A with HIV cure scientific superstars

What’s going on in HIV cure research? Is it ethical to take people off of HIV antiretrovirals if they participate in HIV cure research? These were some of the questions that lead researchers who are part of the amfAR Institute for HIV Cure Research at UCSF tackled at a forum on World AIDS Day this year.

Published
22 December 2016
From
BETA blog
NIH Scientists Identify Potent Antibody that Neutralizes Nearly All HIV Strains

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class. The remarkable breadth and potency of this antibody, named N6, make it an attractive candidate for further development to potentially treat or prevent HIV infection, say the researchers.

Published
17 November 2016
From
National Institute of Allergy and Infectious Diseases
J&J vaccine plus Gilead immune booster shows promise as HIV fighter

An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the virus at bay in monkeys even after treatments had stopped, marking yet another step toward the development of a so-called functional cure for HIV.

Published
10 November 2016
From
Reuters
Huge diversity in current HIV vaccine research, Research for Prevention conference hears

The HIV vaccine research field is currently going through probably its most fertile and diverse period yet, the second HIV Research for Prevention conference (HIVR4P) in Chicago

Published
23 October 2016
By
Gus Cairns
Gene therapy goes global: Portable device could make future cancer, HIV cures affordable

A tabletop device that enables medical staff to genetically manipulate a patient’s blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multimillion-dollar “clean rooms,” making gene therapy more possible for even the poorest of countries.

Published
21 October 2016
From
Fred Hutchinson Cancer Research Center
HIV active in tissues of patients who were treated, study shows

UCSF researchers have found in autopsy tissue samples of patients treated with antiretrovirals that the virus evolved and migrated among tissues similar to the way it did in patients who had never received antiretroviral treatment, despite the fact that the treated patients had undetectable levels of virus in their blood.

Published
20 October 2016
From
Eurekalert Inf Dis
Crohn’s disease drug produces long-lasting viral undetectability and T-cell restoration off treatment in monkeys

In a promising experiment in rhesus macaque monkeys, scientists from Emory University in Atlanta have used a monkey-adapted version of vedolizumab (Entyvio), a drug used to treat gut

Published
14 October 2016
By
Gus Cairns
Antibody treatment surprisingly 'cures' monkeys of HIV-like infection

In Science today, a team led by immunologist Aftab Ansari of Emory University School of Medicine in Atlanta describes infecting eight monkeys with SIV, the simian version of HIV, treating them with ARVs, and then infusing them with an antibody similar to an approved drug for Crohn's disease and ulcerative colitis that targets a receptor on immune cell surfaces known as α4ß7.

Published
14 October 2016
From
Science
← First12345...40Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.